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Abstract
Background: In vertebrates, a large part of gene transcriptional regulation is operated by cis-
regulatory modules. These modules are believed to be regulating much of the tissue-specificity of
gene expression.
Results: We develop a Bayesian network approach for identifying cis-regulatory modules likely to
regulate tissue-specific expression. The network integrates predicted transcription factor binding
site information, transcription factor expression data, and target gene expression data. At its core
is a regression tree modeling the effect of combinations of transcription factors bound to a module.
A new unsupervised EM-like algorithm is developed to learn the parameters of the network,
including the regression tree structure.
Conclusion: Our approach is shown to accurately identify known human liver and erythroid-
specific modules. When applied to the prediction of tissue-specific modules in 10 different tissues,
the network predicts a number of important transcription factor combinations whose concerted
binding is associated to specific expression.
Background
A cis-regulatory module (CRMs) is a DNA region of a few
hundred base pairs consisting of a cluster of transcription
factor (TF) binding sites [1]. By binding CRMs, transcrip-
tion factors either enhance or repress the transcription of
one or more nearby genes. Coordinated binding of several
transcription factors to the same CRM is often required for
transcriptional activation, thus allowing a very specific
regulatory control.
High-throughput experimental identification of CRMs
remains inaccessible, especially for distal enhancers.
Methods like genomic localization assays (also known as
ChIP-chip) using whole genome tilling arrays may soon
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improve the situation, but the cost of such extremely large
arrays will limit their utilization. Because of this, several
computational approaches have been developed for pre-
dicting cis-regulatory modules. Some attempt to identify
regulatory modules with a particular function (e.g. muscle
[2] or liver [3] specific CRMs, and many others [4-6]) by
building or learning a model of the binding site content
of such modules, based on a set of known modules. These
methods generally obtain a reasonable specificity, but
their applicability is limited to the few tissues, cell types,
or conditions for which sufficiently many experimentally
verified modules can be used for training. Others seek
more generic signatures of cis-regulatory regions, like
inter-species sequence conservation [7], sequence compo-
sition [8], or homotypic and heterotypic binding site clus-
tering [9,10]. These methods are more widely applicable,
but their predictions may be of lesser accuracy, because
they do not rely on any prior knowledge. Furthermore, the
predictions made by these algorithms are not accompa-
nied by any annotation regarding the putative function of
the modules. The PReMod database [11] contains more
than 100,000 human CRM computational predictions,
mostly consisting of putative distal enhancers.
By adjoining other types of information to the predicted
module information, additional insights can be gained
into the function of specific modules. For example, in
yeast, Beer and Tavazoie have used gene expression data to
train a algorithm to predict expression data based on
sequence information. In human, Blanchette et al. [12]
and Pennacchio et al. [13] have used tissue-specific gene
expression data from the GNF Altas2 [14] to identify cer-
tain transcription factors involved in tissue-specific regu-
lation and Pennachhio et al. [13] have further developed
models to predict the tissues-specificity of regulatory
modules based on their binding site content. In this
paper, we propose a new approach to the detection of tis-
sue-specific cis-regulatory modules. Our algorithm uses a
Bayesian network to combine binding site predictions
and tissue-specific expression data for both transcription
factors and target genes. It identifies the transcription fac-
tors and combinations thereof whose presence bound to
a module appears to be resulting in tissue-specific expres-
sion. Our approach takes advantage of the facts that tis-
sue-specific CRMs are likely 1) to be located next to genes
expressed in that same tissue, 2) to contain many binding
sites for TFs that are also expressed in that tissue, and (3)
to contain binding sites whose presence in other modules
also appears to be associated to tissue-specific expression.
Our approach falls under the category of unsupervised
learning, as it does not rely on any labeled training set or
any type of prior knowledge regarding the TFs that may be
important for a given tissue.
Importantly, the Bayesian network contains at its core a
regression tree to represent the dependence between the
regulatory activity of a CRM and the set of TFs predicted to
bind it. A new unsupervised Expectation-Maximization-
like algorithm is developed to infer the parameters of the
network, including the structure of the regression tree.
Our approach is related to that of Segal et al. [15,16] but
differs in that it takes advantage of available TF position
weight matrices and TF expression data to allow tissue-
specificity predictions. Moreover, based on the candidate
modules predicted by PReMod, our approach is allowed
to detect distal enhancers that are involved in tissue-spe-
cific expression.
We show that our method is able to accurately discrimi-
nate between known liver and erythroid-specific modules,
even in the presence of a large fraction of modules with
neither function, by discovering important combinations
of transcription factors associated to these tissues. When
applied to a larger set of putative modules and tissues, sev-
eral known tissue-specific TFs were recovered, and many
interesting new TF combinations were predicted to be
linked to tissue-specific expression.
Methods
The goal of the method developed in this paper is to pre-
dict whether a given putative cis-regulatory module is
responsible (at least in part) for the expression of a given
gene in a particular tissue. Since the problem of predicting
regulatory modules has already been studied extensively,
we assume that a set of candidate CRMs
 has been identified in the genome
under consideration and we focus on determining their
tissue-specificity. We emphasize that many of these pre-
dicted CRMs are likely to be false-positives (i.e. they have
no regulatory function whatsoever), and most are proba-
bly not specific to any tissue; our goal is to identify those
that are. Given a putative CRM Mm, a gene G, and a tissue
(or cell type) T, we want to determine whether module
Mm up-regulates gene G in tissue T. (We focus only on the
identification of enhancers, rather than repressors,
because it is difficult to distinguish between repressed
genes and genes that are not expressed due to the lack of
activators.) To this end, we define a Bayesian network that
is used to combine various types of evidence, including
the putative transcription factor binding sites contained in
Mm, the expression levels of the set of transcription factors
predicted to bind Mm, and the expression level of gene G.
Importantly, and perhaps counter-intuitively, we train a
single Bayesian network that will be applicable to predict-
ing tissue-specific regulatory modules in all  the tissues

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considered. This stems from the hypothesis that the
enhancer activity of a module should depend only on its
binding site content and on the expression levels of the
transcription factors binding it, and not directly on the tis-
sue considered. By allowing sharing regulatory mecha-
nisms across tissues, we hope to improve our sensitivity to
subtle regulatory mechanisms. One obvious drawback of
this method is that unobserved entities like the presence
or absence of tissue-specific transcriptional co-activators
may affect the regulatory effect of a given module in dif-
ferent tissues even if the set of TFs bound to it does not
change.
Typically, a Bayesian network consists of a set of observed
variables, a set of unobserved variables, and an acyclic
directed graph describing the direct dependencies
between these. In this section, we first introduce the set of
variables present in our network, which is depicted in Fig-
ure 1. We then describe the dependencies between these
variables and the algorithms used to learn the parameters
of the network.
Bayesian network variables
Let  Φ = {Φ1,...,Φ|Φ|} be a set transcription factors, let
 be a set of tissue (or cell) types, let
 be the set of all known human protein-
coding genes, and let   be a set of pre-
dicted cis-regulatory modules. Since the notation describ-
ing the network requires many types of subscripts, we
adopt the following convention: Right-subscripts refer to
transcription factor indices; Right-superscripts refer to
module indices; Left-superscripts refer to tissue indices;
Left-subscripts refer to gene indices (for example,

 = { ,..., } 1TT
  = { ,..., } 1GG

 = { ,..., } MM 1
The bayesian network used for predicting tissue-specific regulatory modules Figure 1
The bayesian network used for predicting tissue-specific regulatory modules. See section 'Bayesian network variables' for a 
description of the variables, and section 'Bayesian network architecture' for a description of their dependencies.BMC Bioinformatics 2007, 8(Suppl 10):S2 http://www.biomedcentral.com/1471-2105/8/S10/S2
Page 4 of 17
(page number not for citation purposes)
). We start by defining the observed varia-
bles for our network, shown in unshaded ovals in Figure
1. More detailed definitions pertaining to the specific data
set analyzed in this paper will be found in Section 'Data
sets'. Consider the following domains of index variables:
1 ≤ m ≤ | |, 1 ≤ f ≤ |Φ|, 1 ≤ g ≤ | |, and 1 ≤ t ≤ || .
•   is the real-number predicted affinity of transcrip-
tion factor Φf for module Mm. It should reflect our confi-
dence that, provided factor Φf is expressed, it will bind
module Mm. It is a function of the number and the quality
of Φf's predicted binding sites in Mm.
￿ tFf is a boolean variable describing whether transcription
factor Φf is expressed in tissue tT.
￿   is a boolean variable describing whether gene g is
expressed in tissue tT.
To model the relationships between the observed varia-
bles, it is necessary to introduce a set of hidden variables.
￿   is the actual state (active or inactive) of transcrip-
tion factor Φf in tissue tT. State   may not equal the
observed expression level tFf because of post-transcrip-
tional regulation (e.g. activation due to external stimuli
for nuclear receptors) or errors in the measurements of
mRNA abundance.
￿   is the actual transcriptional status (transcribed or
not transcribed) of gene gG in tissue tT, which could be dif-
ferent from the observed mRNA abundance   because
of mRNA degradation or errors in the measurements of
mRNA abundance.
￿   is a boolean variable indicating whether, in tissue
tT, module Mm is bound by sufficiently many copies of fac-
tor Φf for this factor to achieve its function.
￿ The fact that a module is bound by a transcription factor
does not necessarily translate into this module being reg-
ulatorily active. Indeed, the presence of other transcrip-
tion factors may be required for the module to become
active. We represent the regulatory activity of module Mm
in tissue tT by a boolean variable tRm, which takes the
value 1 when the module Mm actively (and positively) reg-
ulates its gene. This is the variable whose value is of the
most interest for predicting tissue-specific regulatory
modules.
We acknowledge that using binary variables to represent
expression levels and regulatory activity is a very crude
approximation. Although all these variable should in the-
ory be continuous, the quantitative relations between
transcription factor expression levels, their binding affin-
ity to a module, and the contribution of that module to
the expression of the target gene remain poorly under-
stood, so a more qualitative approach is preferable. Fur-
thermore, due to the computational complexity of
network inference, such a simplification was necessary. In
fact, by reducing the size of the parameter search space,
this simplification might actually be improving generali-
zation from small data sets.
Bayesian network architecture
In a Bayesian network, dependencies between variables
are modeled as directed edges connecting the cause to the
effect. The conditional probability of a node given the
value of its parent(s) is described by a set of parameters
that are either fixed or learned from the data. When the
variables at hand have a finite domain, these conditional
probabilities can be represented by a conditional proba-
bility table (CPT).
Conditional distributions of E and F
The observed expression levels E and F depend on the true
expression levels   and   respectively. Since all variables
are boolean, the conditional probability tables are the fol-
lowing:
Here, αE and βE are the probabilities of false-positive and
false-negative in the discretized gene expression data,
respectively. We assume that these parameters are shared
among all genes, i.e. expression measurement errors are
equally likely for all genes. Similarly, αF and βF are the
probabilities that the discretized expression measurement
tissue
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for a given factor does not reflect their actual regulatory
potency. Again, these parameters are shared among all
transcription factors, although this might to be inaccurate
for factors like nuclear receptors, which require external
signals for activation.
Conditional distribution of B
The probability of  , the random variable that
describes whether module Mm is bound by factor Φf in tis-
sue tT, depends on whether the factor is expressed in that
tissue, and on the affinity   of the factor for that mod-
ule. We assume that the parameters describing this condi-
tional probability are the same for all m and t, so we drop
some subscripts and superscripts to write Pr[Bf|Af, Ff]. We
model this conditional probability indirectly, by instead
modeling Pr[Af|Bf = 1], the distribution of binding site
affinities for a module that is bound, using a normal dis-
tribution with parameters μf and   that will be esti-
mated during training. Since the mathematical derivation
is tedious (but relatively simple), it is left in Appendix 1.
Conditional distribution of R using regression trees
The most challenging set of conditional probabilities to
represent is that of tRm, which depends on the values of
. Again, we assume the parameters that
describe this dependency are the same for all tissues tT and
all module Mm, so we drop these indices. This assumption
is equivalent to saying that the regulatory effect of the
binding of a certain set of transcription factors does not
depend on the module bound, the gene being regulated,
or the tissue type.
How should we represent the probability that a module is
regulatorily active, given the set of transcription factors
bound to it, i.e. Pr[R|B1,..., ]? Given that all variables
are boolean, this conditional probability can be repre-
sented by a   × 2 CPT containing   parameters. In
our application where   contains several hundred tran-
scription factors, this is obviously not practical, because
(1) the CPT would be too large to store, and (2) we would
need a huge amount of training data to learn the parame-
ters. We thus use a more compact representation for this
CPT, based on regression trees [17]. A regression tree is a
rooted tree whose internal nodes are labeled with tests on
the value of some variable Bf. See Figure 2 for a small
example. For boolean variables (our case here), each node
N tests whether the some variable   takes the value true
or false. Each leaf l of the tree is associated with a proba-
bility distribution Pr[R|l]. Let
 be the set of variable assign-
ments obtained by following the path from the root to l.
Let l(b1,..., ) be the leaf reached when B1 = b1,...,  =
. Then, the regression tree defines a complete condi-
tional probability distribution: Pr[R|B1 = b1,...  =  ]
= p(l(b1,..., )). When many of the Bi's are irrelevant to
R, the representation is much more compact than the
standard CPT and can be estimated from less data. We will
jointly refer to the tree topology, the node labelings, and
the probability distributions at the leaves as the meta-
parameter Ψ. Inferring Ψ will be the most significant dif-
ficulty of this approach.
Conditional distribution of 
The last set of dependencies is that of a gene's transcrip-
tional activity   on the regulatory activity of the neigh-
boring regulatory modules. This raises the difficult
question of determining which gene is being regulated by
each module. This is relatively straight-forward when the
module is located in the promoter region of a gene, but
much less so when it is located 100 kb away from any
gene. Here, for lack of more accurate information, we
assume that a module Mm only has the potential of regu-
lating the gene gG whose transcription start site is the clos-
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Example of a regression tree representing a small 2-variable 
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est to it, denoted closest(Mm). Then the expression level of
gene gG depends on regulators(gG) = {m|closest(Mm) = gG}
= {r1, r2,...}. We will assume that the expression level of gG
only depends on the number of its modules that are
active, through a sigmoid function:
,
where a and b are user-defined parameters (see Appendix
3).
Learning the network's parameters
Our Bayesian network contains a number of parameters
whose values are not known a priori. We collectively refer
to these parameters as  .
The network will be trained using the set of all pairs (mod-
ule, tissue). Let A, E, and F be the set of all TF affinity data,
all gene expression data, and all TF expression data,
respectively, over all tissues considered. A typical
approach to estimating the network's parameters is to seek
the value Θ* that maximizes the joint likelihood of the
observed variables, i.e. Θ* = argmaxΘPr[A, E, F].
An Expectation-Maximization algorithm can be used to
learn the parameters Θ of the Bayesian network [18],
whereby a local maximum of the likelihood function is
reached by alternatively estimating the expected value of
hidden variables given the observed variables and the cur-
rent estimate Θ0, and then reestimating the maximum
likelihood values for the parameters Θ. However, since Θ
contains the tree structure, we cannot apply the standard
EM algorithm for learning Bayesian networks, as this algo-
rithm relies on the ability to analytically derive a maxi-
mum likelihood estimate for the parameters (see however
[18]). Instead, a new EM-like algorithm with regression
tree learning is developed to infer the tree within the net-
work.
Estimating posterior probabilities for hidden variables
Our first step is to calculate the expectation (or equiva-
lently, the probability of taking the value 1, since all hid-
den variables are binary), for all hidden variables, given
the value of the observed variables. These posterior prob-
abilities can be calculated using the formulas given in
Appendix 2. The derivation of most of these formulas is
fairly straight-forward, except for the calculations involv-
ing the regression tree. Computing
 can
be done efficiently thanks to the regression tree represen-
tation.
Maximum likelihood parameter estimation
Once the posterior probabilities of the hidden variables
are computed, maximum likelihood estimators for the
parameters of the network can be derived as given in
Appendix 3. Again, the regression tree representing the
dependence of R  on  B1,...,  poses significant chal-
lenge, as no efficient algorithm exists to choose the tree
topology  . Instead, we developed a new tree learning
algorithm, which adapts ideas from standard decision tree
algorithms (e.g. C 4.5 [19], J48 [20]). The problem at
hand is novel and challenging for several reasons:
1. Soft attributes: The input variables   are binary var-
iables, but their values remain unknown at any given iter-
ation of the EM-like algorithm. Only their distribution
Pr[ |A, E, F] is known for each m, f and t, given the
current estimate of the parameters Θ.
2. Soft labels: The values of the target variables tRm are also
unknown, but their distribution Pr[tRm|A, E, F] is known.
Learning regression trees from probabilistic instances
Most decision tree learning algorithms are based on a
greedy tree-growing approach trying to find the tree that
minimizes the number of misclassifications [21]. Our tree
learning algorithm is an adaptation of the standard
approach using information gain as a method to select
which attribute to select to split a node. Consider a node
N that is currently a leaf and that we are considering split-
ting based on some attribute Bi. The weight of a probabil-
istic instance   is the probability of the
path from the root to N, under the attribute probability
distributions given by x.
More precisely,
We can now define the weighted entropy at node N as:
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where
,
and totalWeight(N) = ∑t ∑mweightN(m, t). Then, the infor-
mation gain obtained by splitting a leaf N with attribute
Bi to obtain two new leaves N' and N" is defined as
The attribute Bi with the largest weighted information gain
is chosen as label for N and corresponding children nodes
N' and N" are added. The tree grows this way until no pair
of node and attribute yields a positive information gain.
This is a very loose stopping criterion and trees learned
this way tend to be very large.
In order to avoid the problem of overfitting, a method
called reduced-error pruning is used [21]. It uses a sepa-
rate validation data set to prune the tree, and each split
node in the tree is considered to be a candidate for prun-
ing. When pruning a node, a operation called subtree
replacement is performed, which involves removing the
subtree rooted at that node and replacing the subtree with
a single leaf. Whether pruning is performed depends on
the classification accuracy obtained by the unpruned tree
and by the pruned tree over the validation set. Pruning
will cause the accuracy over the training data set to
decrease; but it may increase the accuracy over the test
data set.
Results
Our approach was used to identify tissue-specific CRMs in
human. First, we show, using a small set of experimentally
verified tissue-specific CRMs, that our approach is able to
discriminate between modules involved in different tis-
sues. Then, we apply our method to a larger data set con-
sisting of more than 6000 putative CRMs associated to
genes specifically expressed in one of ten tissues, and
show that interesting combinations of transcription fac-
tors can be linked to tissue-specific expression.
Data sets
We used a set of cis-regulatory modules predicted in the
human genome by Blanchette et al. [12], based on a set of
481 position weight matrices from Transfac 7.2 [22]. The
modules are available from the PReMod database [11].
Criteria used for the PReMod predictions include inter-
species conservation of binding site predictions and
homotypic clustering of binding sites. The complete data
set consists of more than 100,000 predicted CRMs, but
only subsets of those were used (see below). For each pre-
dicted module Mm, the predicted binding affinity   is
represented by the negative logarithm of the p-value of the
binding site weighted density for factor Φf in module Mm,
as reported in PReMod. Gene expression data came from
the GNF Atlas 2 data set [14], downloaded from the UCSC
Genome Browser [23]. A gene gG  was identified as
"expressed" (i.e.   = 1) if and only if its expression level
was at least two standard deviations above its mean
expression level, over the 79 tissues for which data was
available.
Only 231 of the 481 Transfac PWMs were confidently
linked to transcription factors for which GNF expression
data is available. Only these | | = 231 PWMs were con-
sidered in our analysis. Some transcription factors are
actually linked to several different PWMs, but our
approach actually seems to take advantage of this to
improve the quality of the predictions (see below).
Validation experiments
We first use a set of experimentally verified tissue-specific
CRMs, together with a set of negative control regions, to
validate our algorithm. To further evaluate the perform-
ance of our approach, we compare our results with the
results obtained with several simpler classifiers.
Validation data sets
To demonstrated the ability of our approach to identify
tissue-specific regulatory modules, we used it to discrimi-
nate between known liver-specific CRMs, known eryth-
roid-specific CRMs, and other modules not likely to be
involved in these two cell types. Each validation data set
was composed of five subsets:
1. knownLiver: 11 experimentally verified liver-specific
modules [3].
2. knownErythroid: 22 experimentally verified erythroid-
specific modules [24].
3. putativeLiver: A set of 31 PReMod modules located in
the vicinity of the genes associated to the knownLiver
modules. These modules are possibly involved in liver-
specific regulation and are included only to help the Baye-
sian network learning the association between a module's
binding site composition and tissue-specificity of the tar-
get gene.
4. putativeErythroid: A set of 46 PReMod modules similar
to (3) but for erythroid.
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5. negative: For each knownErythroid or knownLiver
module with associated closest gene g, a set of rneg (see
below) PReMod modules associated to genes that are
expressed in neither erythroid nor liver is randomly
selected and artificially associated to gene g. These are
modules that, if placed in the vicinity of gene g, would be
unlikely to cause liver or erythroid-specific expression.
The ratio rneg of the number of negative modules to the
number of known modules determines in part the diffi-
culty of the classification task. Two types of validation
data sets were thus created: In our 1X experiment (see
below), we used rneg = 1, whereas in our 2X data set, we
used rneg = 2.
Each 1X data set thus contains 143 modules, each of
which was considered as a possible liver or erythroid spe-
cific. The complete data set consists of 2 × 143 = 286 mod-
ule-tissue pair, of which 11 + 22 = 33 are positive
examples, 99 are negative examples (all the knownLiver
modules when considered in the erythroid cell type, all
the knownErythroid modules when considered in liver,
and all the negative modules in both tissues). The 2X data-
sets are similar, except that they are noisier because they
contain 165 negative examples.
Three simple classifiers
To assess the quality of our method, we compare it to
three other simpler approaches. The first classifier, called
the expressionOnly classifier, simply predicts that any mod-
ule located next to a gene that is expressed in a given tissue
is a tissue-specific module for that tissue. That is, the bind-
ing site content of the module is ignored, and only the
expression gE is used to make the prediction.
The second simple classifier, called SupervisedNaiveBayes,
is a classical supervised Naive Bayes approach that takes as
input a simplified, observable version of the B variables,
where we set   = Fm·Af, as well as the expression of the
target gene   and is trained to distinguish between
labeled positive and negative examples (see Appendix 4
for the complete details). Finally, the third simple classi-
fier, called NaiveBayesInNet, is a version of our Bayesian
Network classifier in which the regression tree represent-
ing the conditional probability of R is replaced by a Naive
Bayes classifier, but where the rest of the structure is pre-
served. See Appendix 5 for more details.
Validation results
One hundred different runs of our EM-like algorithm
were done on 1X and 2X datasets, each time with a differ-
ent sample of negative modules. Each run used 100 EM-
like iterations (taking approximately 10 minutes of run-
ning time), which was sufficient to achieve convergence,
although different runs converge to slightly different like-
lihoods and regression trees (see Additional File 1). Since
we do not know which of the putativeLiver and puta-
tiveErythroid CRMs are actually tissue-specific modules,
we evaluate the performance of our algorithm based only
on the positive and the negative modules. For each run,
the network with the best likelihood over 100 EM-like
iterations is used to compute Pr[tRm|A, E, F] for all exam-
ples and a module-tissue pair is predicted positive if this
probability exceed some threshold t. The resulting preci-
sion-recall curve, averaged over all 100 runs, is shown in
Figure 3, for both the 1X and 2X data set.
Since 13 out of the 33 known CRMs have target genes
expressed neither in liver nor in erythroid (based on our
discretization of expression data), the ExpressionOnly clas-
sifier yields a recall = 60.6% and precision = 50% on the
1X data set, but only precision = 33% on the 2X data set.
As seen from the curves, our method significantly outper-
forms both the Naive Bayes-based approaches for mid- to
high-precision predictions. Our method can improve the
precision to 72% for the 1X data sets and 66.2% for the 2X
data sets. Notice that the highest precision for the 2X data
sets remains close to that for the 1X data sets, although
almost twice as many negative examples are considered.
This indicates that our approach provides a way to
improve the precision of prediction by combining the
sequence data and the expression data.
Regression trees
Figure 4 shows the regression trees generated from one
run for the 1X and 2X data sets. Each internal node tests
the value of an attribute Bf, which indicates whether factor
Φf is predicted to bind the module in the tissue under con-
sideration. Each leaf shows the conditional probability
predicted, which is the probability of R = 1 on the condi-
tion specified by the path from to root to the leaf.
The tree structure indicates what are the most important
TFs or combinations of TFs for explaining liver-specific
and erythroid-specific expression. Our algorithm success-
fully detects most known liver-specific TFs and combina-
tions of thereof, like HNF1 + HNF4, HNF1 + C/EBP, and
HNF4 + C/EBP, which are reported in the literature [3].
The erythroid-specific TF GATA1 is also reported in the
trees. The trees do not contain many erythroid-specific
nodes, firstly because there are only two TFs (GATA1 and
NF-E2) that are erythroid-specific based on our expression
data, and secondly because NF-E2 has very few predicted
binding sites on the genome. We observe from the trees
that the leaves associated with TF combinations usually
have higher regulatory probabilities than the leaves asso-
ciated with individual TFs. This indicates that the ability to
Bm
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identify TF combinations is key to being able to identify
cis-regulatory modules. We emphasize that the trees were
obtained without any prior information about which of
the 231 PWMs used are involved in liver or erythroid-spe-
cific expression.
Notice that TF PPAR  is reported in our trees. PPAR  is
indeed an important factor regulating expression in liver
[25], but was absent from Krivan and Wasserman's paper
[3] from which we obtain the known liver-specific CRMs.
Most importantly, the expression of PPAR is low in both
liver and erythroid, so erythroidFPPAR =  liverFPPAR = 0. This
shows that our approach is robust to noise in the expres-
sion data of TFs, provided the association between the
binding sites in modules and the target gene's expression
is sufficiently high. Finally, we note the unexpected selec-
tion of several different matrices for the same transcrip-
tion factor along the same path in the tree (for example C/
EBP M770 and M190 on the tree obtained for the 1X data
set on Figure 3). This is caused by the fact that these matri-
ces are quite actually different from each other, but the
presence of sites for both matrices increases the associa-
tion to the target gene's expression.
Genome-wide CRM prediction in ten tissues
We next extended our analysis to ten different tissues from
the GNF Atlas2:   = {brain, erythroid, thyroid, pancre-
atic islets, heart, skeletal muscle, uterus, lung, kidney, and
liver}. 923 genes are specifically expressed (i.e.   = 1) in
at least one of these tissues and a total of 6278 modules
are associated to these genes. We thus trained our Baye-
sian network on a set of 10 × 6, 278 = 62, 780 (module,
tissue) pairs. Ten parallel runs of 100 EM-like iterations
were performed from different random initializations,
each taking approximately 24 hours.
The regression tree obtained obtained from the best run is
shown in Figure 5. We can clearly observe from the tree
that the positive assignments along each path leading to a
leaf typically consists of TFs expressed in the same tissue.
Several known tissue-specific combinations of TFs are
recovered in the tree, such as C/EBP + HNF1 and C/EBP +
HNF4 in liver. Also, many new and potentially meaning-
ful TF combinations are predicted, such as C/EBP + AR in
liver and Tax/CREB + GATA1 in erythroid.
The tree only contains the TFs expressed in four tissues:
liver, erythroid, heart, and skeletal muscle. The other six
tissues are not represented in the tree because of one of the
following reasons: (1) The TFs that regulate the genes
expressed in those tissues have low expression levels. (2)
These TFs do not have strict requirements for sequence
affinity, so the binding scores of their matrices are low. It
is also possible that there are no PWMs for such TFs. (3)
The expression of genes in those tissues are controlled by
post-transcriptional regulation instead of tissue-specific
TFs. 
g
tE
The precision v.s. recall curve for the 1X (left) and 2X (right) data sets, where precision = TP/(TP + FP) and recall = TP/(TP +  FN) Figure 3
The precision v.s. recall curve for the 1X (left) and 2X (right) data sets, where precision = TP/(TP + FP) and recall = TP/(TP + 
FN). The blue curve (diamond markers) is generated from the results of our approach, the brown curve (× markers) is gener-
ated from the results of the Supervised-NaiveBayes approach (see Appendix 4), and the green curve (circle markers) is gener-
ated from the results of the NaiveBayesInNet classifier (see Appendix 5). The pink triangle shows the result obtained by the 
expressionOnly classifier. Error bars denote one standard deviation of the precision, over 100 random choices of negative 
examples. The increase in the standard deviation on precision at lower recall is due to the small number of predictions made 
for these thresholds.
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The regression tree generated by the iteration with the best likelihood for a 1X (top) and 2X (bottom) data sets Figure 4
The regression tree generated by the iteration with the best likelihood for a 1X (top) and 2X (bottom) data sets. Internal 
nodes corresponding to liver-specific transcription factors are colored yellow, and those corresponding to erythroid-specific 
factors are red.
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Regression tree obtained from the best of ten runs on the set of 6,278 modules and 10 tissues Figure 5
Regression tree obtained from the best of ten runs on the set of 6,278 modules and 10 tissues. Nodes are colored based on 
the tissue in which a particular factor is expressed.
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The complete set of tissue-specificity predictions are avail-
able at http://www.mcb.mcgill.ca/~xiaoyu/tissue-specific
Module.
Statistical analysis of TF combinations
The regression trees obtained in the 10 runs vary substan-
tially in their structure but share many of their factors and
combination of factors. The frequency with which factors
or combination of factors are found in these trees is an
indication of their role in regulating tissue-specific expres-
sion. A pair of factors is said to co-occur in a regression
tree if the tree contains a path along which both factors
take value 1. As seen in Tables 1 and 2, several factors and
pairs of factors are consistently identified as part of the
Table 1: Significant TFs selected in the 10-tissue experiment.
Transcription factor Number of occurrences Expressed in tissue(s) Support from literature
HNF1 10 Liver [27]
C/EBP 10 Liver [27]
C/EBPalpha 10 Liver [27]
AR 8 Liver [28]
Sp1 8 Erythroid [29]
E2F 7 Erythroid [30]
MAZ 7 Erythroid [31]
Tax/CREB 7 Erythroid [32]
GATA1 7 Erythroid [33]
ERRalpha 6 Liver, Heart [34]
CREB 6 Erythroid [32]
HNF4 6 Liver, Skeletal muscle [27]
YY1 5 Erythroid [35]
Cdx2 5 Skeletal muscle
LXR 5 Liver [36]
GATA4 5 Heart [37]
RFX1 5 Skeletal muscle
XBP1 5 Liver, Pancreatic islets [38]
N-Myc 5 Heart [39]
Transcription factors present in the regression tree in at least five of the 10 runs. References in bold refer to papers arguing for tissue-specificity of 
the given factor in the given tissue, whereas those in normal font point to papers showing the involvement of the given TF for the proper 
expression of some gene(s) expressed in the given tissue, but where the TF is not tissue-specific.
Table 2: Significant TFs pairs selected in the 10-tissue experiment.
Transcription factor pair Number of occurrences Expressed in tissue(s)
C/EBP + C/EBPalpha 10 Liver
HNF1 + C/EBP 7 Liver
HNF1 + C/EBPalpha 5 Liver
Tax/CREB + MAZ 5 Erythroid
Sp1 + E2F 4 Erythroid
C/EBP + AR 4 Liver
C/EBP + CHOP-C/EBPalpha 4 Liver
CREB + Tax/CREB 4 Erythroid
GATA1 + Sp1 4 Erythroid
GATA1 + CREB 4 Erythroid
GATA1 + YY1 4 Erythroid
AR + LXR 3 Liver
CREB + MAZ 3 Erythroid
HNF4 + AR 3 Liver
Tax/CREB + E2F 3 Erythroid
GATA1 + E2F 3 Erythroid
GATA1 + Tax/CREB 3 Erythroid
YY1 + Tax/CREB 3 Erythroid
YY1 + CREB 3 Erythroid
Sp1 + Tax/CREB 3 Erythroid
Transcription factor pairs present together on the same path of the regression tree in at least three of the 10 runs.BMC Bioinformatics 2007, 8(Suppl 10):S2 http://www.biomedcentral.com/1471-2105/8/S10/S2
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tree. Most TFs found are either known to be directly
involved in tissue-specific regulation (in bold in Table 1,
or to be essential for the expression of certain genes in the
given tissues, but to also have other non-tissues-specific
roles (normal font in Table 1).
Predicting gene tissue-specificity
To further validate our module tissue-specificity predic-
tions, we investigated whether a gene's tissue-specific fine-
grain expression level could be predicted based on the
modules regulating it. To this end, for each tissue t, we
separated genes between highly expressed  ) and low
expressed (  = 0). Let   be the maximum of the pre-
dicted regulatory activity tRm of the modules associated to
gene g. We asked whether   is predictive of the raw,
non-thresholded expression level of gene g. In the case of
genes with   = 0, such a correlation would show that we
are able to detect tissue-specific genes even if their expres-
sion level is below the threshold. For genes with   = 1,
this correlation would show that genes with very high tis-
sue-specific expression levels are associated to stronger
module predictions than those that barely meet our
threshold. We note that in both cases, such a correlation
could not be explained by any kind of training artifact,
since raw expression data is not part of the input.
Considering genes showing tissue-specific expression
(  = 1), we find that eight of the ten tissues considered
(all but "whole brain" and "erythroid") exhibit a positive
correlation between   and the raw gene expression.
Somewhat surprinsingly, the correlation is strongest for
thyroid (p-value = 0.028) and skeletal muscle (p-value =
0.015), two factors that were relatively poorly represented
in our regression tree. Among genes with   = 0, the cor-
relation is weaker but is positive in seven of the ten tissues
(all except heart, skeletal muscle, and liver). These results
indicate that our predictions yield a weak predictor of
gene tissue-specificity. Clearly, it is easier to predict mod-
ules responsible for a gene's observed tissue-specificity
than to predict the tissue-specificity of a gene based on its
modules.
Discussion and conclusion
The approach we introduced here is the first to integrate
binding site predictions and tissue-specificity of expres-
sion of both transcription factors and target genes to pre-
dict cis-regulatory modules involved in regulating tissue-
specific gene expression. By introducing a regression tree
at the heart of the network and deriving practical algo-
rithms to train it, we are able to accurately identify impor-
tant combinations of transcription factors regulating gene
expression in a tissue-specific manner. The algorithms
derived for learning this type of network will undoubtedly
be applicable to a wide range of problems.
Many of the choices made in the design of the Bayesian
network were made for computational practicality rea-
sons. As we improve the learning algorithm, it will
become possible to use real-numbered expression meas-
urements.
Furthermore, our network could easily be extended by
introducing additional sources of information as
observed variables. For example, ChIP-chip and other
binding assay data, when available, can be used to affect
our belief in  . Reporter assays and DNA accessibility
assays could be used to modify our belief in tRm. If mod-
eled correctly, these types of experimental data may
greatly increase the accuracy of our predictions, not only
for the modules or the factors for which data is available,
but also for other regions or factors associated to similar
functions.
The approach we described is potentially applicable to a
wide range of data sets. While the relative inefficiency of
the current learning algorithm prevented us from analyz-
ing the complete set of tissue-specific expression from
GNF, it is clear that this analysis, involving 79 tissues,
would yield a wealth of information. Another possible
application is to identify and characterize cis-regulatory
modules involved in time and tissue-specific regulation
during fish development. The large body of in situ hybrid-
ization data available in zebrafish [26] would provide an
excellent basis for this analysis.
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Appendix 1. Calculation of Pr[Bf|Af, Ff]
Pr[Bf|Af, Ff] is the probability of TF Φf binding a genomic
region, given its observed expression Ff and its binding
affinity Af for the region. Modeling this relationship is
challenging because it is unclear how Bf, a binary variable,
should depend on Af, a continuous variable, in the pres-
ence of the observed expression Ff. For this reason, we
derive this probability from a set of other probabilities
distributions that are easier to model, specifically Pr[Af|Bf
= 1], the affinity score distribution of sites that are bound.
Recall that   is defined as the actual expression of factor
Φf. Note first that
for some appropriately chosen constants Z and Z'. The
distribution of Pr[Ff| ] is described in Section 'Condi-
tional distributions of E and F', and the prior probability
Pr[ ] is approximated by the prior probability of the
observed variable Pr[Ff ]. So all that remains is to define
Pr[Af|Bf,  ] and Pr[Bf|] .
Because a TF can bind only if it is expressed, we have
Pr[Af|Bf = 1,   = 0] = Pr[Af|Bf = 1,   = 1] = Pr[Af|Bf = 1]
When   = 0, the event Bf = 0 yields no information on Af,
so
Pr[Af |Bf = 0,   = 0] = Pr[Af]
where the prior probability Pr[Af] is estimated from the
data using a histogram approach.
Notice that
Pr[Af] = Pr[Af, Bf = 0,   = 0] + Pr[Af, Bf = 0,   = 1] + Pr[Af, 
Bf = 1,   = 0] + Pr[Af, Bf = 1,   = 1]
We thus obtain
where
A = Pr[Af]·(1 - Pr[Bf = 0,   = 0])
B = Pr[Af|Bf = 1]·(Pr[Bf = 1,   = 0] + Pr[Bf = 1,   = 1])
and where
Pr[Bf = x,   =  y] = Pr[Bf = x| =  y]·Pr[  = y]
We assume that Pr[Af|Bf = 1] follows a normal distribution
with parameters μf and   that are optimized during the
EM-like algorithm (see Appendix 3). Pr[Ff| ] and Pr[ ]
have all been previously defined.
Finally, Pr[Bf| ] is represented by a fixed CPT:
where γ = 0.01 is a parameter that indicates the prior prob-
ability that an expressed TF will bind a generic genomic
region.
Appendix 2. Formulas for E-step
Calculation of Pr[Rm|A, E, F]
Let X be the set of modules associated with the same gene
g. Let S = ∑r∈XRr, we where
where
￿ The regression tree allows an efficient computation of
the first sum:
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￿ Pr[ | , Ff] has been defined in Appendix 1;
￿ Pr[gE|g ] is represented by a CPT described in Section
'Conditional distributions of E and F';
￿ Pr[g |S = s] is defined by the sigmoid function 1/(1 + e-
b(s-a)).
Further noting that
Pr[S = s|Rm, AX-m, F] = Pr[∑r∈X-mRr = s - Rm|AX-m, F], we can
calculate Pr[S = s|Rm, AX-m, F] by using a simple dynamic
programming.
Calculation of Pr[ |A, B, F]
Note that Pr[ | , Ff] has been defined in Appendix 1.
Furthermore, we can estimate Pr[Rm| ] from the data
where Pr[ |A, E, F] takes the values calculated from
the previous iteration.
We thus get
where Pr[ | , Ff] is obtained as in Appendix 1 and
Pr[ |Ff] = ∑e'∈{0,1}Pr[ |Ff,   =  e']·Pr[  = e'|Ff]/Z.
Calculation of Pr[ |A, F, E] and Pr[ |A, F, E]
Although   is a hidden variable, its posterior probability
distribution does not need to be estimated, because we
sum over all its possible values when computing Pr[Rm|A,
F, gE]. The same holds for   in Pr[Bf|Af, Ff].
Appendix 3. Parameter re-estimation (M-step)
Pr[Af|Bf = 1] is assumed to follow a normal distribution
N(μf, ).
Parameters μf and σf are re-estimated as follows:
In order to avoid overstepping the local maximum, we use
small steps when updating the values of μf and σf. Instead
of replacing the old values with the new values calculated
from Equation 1, we use a hybrid of the old values and the
new values, weighted according to the step size.
where α = 0.1 is the step size.
The following parameters have values that remain fixed
throughout the execution of the EM-like algorithm. Their
value has been chosen empirically to optimize the quality
of the results.
1. Parameters for Pr[E| ] and Pr[F|] :   αE = βE = αF = βF =
0.1
2. Parameters for  :
a = 0.8, b = 10 in validation experiments (small data sets),
and
a = 0.4, b = 10 in discovery experiments (large data set).
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3. Parameters for Pr[Bf|] :   γ = 0.01.
Appendix 4. The SupervisedNaiveBayes classifier
A naive Bayes classifier was trained to discriminate
between positive and negative (module, tissue) pairs.
First, the affinity   is discretized as 1 if and only if its
value is at least one standard deviation above the mean of
Ai, over all 100,000 putative modules from PReMod. The
Naive Bayes network takes as input the following set of
attributes: ,  and  Eg. The precision-recall
curves from Figure 3 were the result of a 11-fold cross-val-
idation experiment.
Appendix 5. The NaiveBayesInNet classifier
The NaiveBayesInNet classifier is a Bayesian Network iden-
tical to the main classifier presented in this paper, except
that a Naive-Bayes-like approach replaces the probability
tree representing Pr[R|B1,...,BΦ]. More specifically, it
assumes Pr[R|B1,...,BΦ] = ∏f=1...ΦPr[Bf|R]/Z.
At each iteration of the EM-like algorithm, Pr[Bf|R] is esti-
mated as
. Then, estimating Pr[R|A, F, E] requires a summation over
all   possible values of the B variables (the simplifica-
tion afforded by the regression tree cannot be applied
here). To make the computation practical, we instead fix
the value of the B to their maximum likelihood estimates
and use these fixed values to estimate Pr[R|A, F, E]. The
approach was trained and evaluated using exactly the
same methodology as for the Bayes network approach
using regression trees.
Additional material
Acknowledgements
We wish to thank Doina Precup, Eric Blais, Emmanuel Mongin, Francois 
Pepin, and two anonymous reviewers for their useful comments. XC was 
funded by Genome Quebec Comparative and Integrative Genomics.
This article has been published as part of BMC Bioinformatics Volume 8 Sup-
plement 10, 2007: Neural Information Processing Systems (NIPS) work-
shop on New Problems and Methods in Computational Biology. The full 
contents of the supplement are available online at http://www.biomedcen 
tral.com/1471-2105/8?issue=S10.
References
1. Davidson EH: Genomic regulatory systems: development and evolution
Academic Press; 2001. 
2. Wasserman W, Fickett J: Identification of regulatory regions
which confer muscle-specific gene expression.  J Mol Biol 1998,
278:167-81.
3. Krivan W, Wasserman W: A predictive model for regulatory
sequences directing liver-specific transcription.  Genome Res
2001, 11(9):1559-66.
4. Aerts S, Loo PV, Thijs G, Moreau Y, Moor BD: Computational
detection of cis-regulatory modules.  Bioinformatics 2003,
19(Suppl 2):II5-II14.
5. Bailey TL, Noble WS: Searching for statistically significant reg-
ulatory modules.  Bioinformatics 2003, 19(Suppl 2):II16-II25.
6. Sinha S, van Nimwegen E, Siggia ED: A probabilistic method to
detect regulatory modules.  Bioinformatics 2003, 19(Suppl
1):i292-301.
7. Prabhakar S, Poulin F, Shoukry M, Afzal V, Rubin E, Couronne O, Pen-
nacchio L: Close sequence comparisons are sufficient to iden-
tify human cis-regulatory elements.  Genome Res 2006,
16(7):855-863.
8. Taylor J, Tyekucheva S, King D, Hardison R, Miller W, Chiaromonte
F:  ESPERR: Learning strong and weak signals in genomic
sequence alignments to identify functional elements.  Genome
Res 2006, 16(12):1596-1604.
9. Philippakis AA, He FS, Bulyk ML: Modulefinder: a tool for compu-
tational discovery of cis regulatory modules.  Pac Symp Biocom-
put 2005:519-30.
10. Johansson O, Alkema W, Wasserman W, Lagergren J: Identification
of functional clusters of transcription factor binding motifs in
genome sequences: the MSCAN algorithm.  Bioinformatics
2003, 19(Suppl 1):i169-76.
11. Ferretti V, Poitras C, Bergeron D, Coulombe B, Robert F, Blanchette
M: PReMod: a database of genome-wide mammalian cis-reg-
ulatory module predictions.  Nucleic Acids Res 2007:D122-6.
12. Blanchette M, Bataille AR, Chen X, Poitras C, Lananiere J, Lefebvre C,
Deblois G, Giguere V, Ferretti V, Bergeron D, Coulombe B, Robert
F: Genome-wide computational prediction of transcriptional
regulatory modules reveals new insights into human gene
expression.  Genome Research 2006, 16(5):656-668.
13. Pennacchio L, Loots G, Nobrega M, Ovcharenko I: Predicting tis-
sue-specific enhancers in the human genome.  Genome Res
2007, 17(2):201-211.
14. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J,
Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch
JB: A gene atlas of the mouse and human protein-encoding
transcriptomes.  Proc Natl Acad Sci USA 2004, 101(16):6062-7.
15. Segal E, Yelensky R, Koller D: Genome-wide discovery of tran-
scriptional modules from DNA sequence and gene expres-
sion.  Bioinformatics 2003, 19(Suppl 1):i273-82.
16. Segal E, Barash Y, Simon I, N F, Koller D: From Promoter
Sequence to Expression: A Probabilistic Framework.  Proc 6th
Inter Conf on Research in Computational Molecular Biology (RECOMB)
2002.
17. Boutilier C, Friedman N, Goldszmidt M, Koller D: Context-specific
independence in Bayesian networks.  Proc Twelfth Conf on Uncer-
tainty in Artificial Intelligence (UAI-96) 1996.
18. Dempster A, Laird N, Rubin D: Maximum likelihood from
incomplete data via the EM algorithm.  J of the Royal Statistical
Society, Series B 1977, 39:1-38.
19. Quinlan J: C4.5: Programs for machine learning Morgan Kaufmann; 1993. 
Additional file 1
The logarithms of the likelihoods for the 2X validation experiments in 
three different randomly selected runs. Different colors represent different 
runs.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-8-S10-S2-S1.jpg]
ˆ Ff
Ai
m
FA F A mm
11 ⋅⋅ ,..., F F
Pr[ | ]
Pr[ | , , ] Pr[ | , , ]
Pr
Ba R b
t
Ba
t
Rb
f
f
m
f
m
m t
== =
=⋅ = = = ∑ ∑ AEF AEF 1 1
 
[ [| , , ]
t
Rb f
m
m t = = = ∑ ∑ AEF 1 1
 
2
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Bioinformatics 2007, 8(Suppl 10):S2 http://www.biomedcentral.com/1471-2105/8/S10/S2
Page 17 of 17
(page number not for citation purposes)
20. Witten I, Frank E: Data Mining: practical machine learning tools with Java
implementations Morgan Kaufmann; 2000. 
21. Mitchell TM: Machine learning McGraw-Hill; 1997. 
22. Matys V, Fricke E, Geffers R, Gössling E, Haubrock M, Hehl R, Hor-
nischer K, Karas D, Kel A, Kel-Margoulis O, Kloos DU, Land S,
Lewicki-Potapov B, Michael H, Münch R, Reuter I, Rotert S, Saxel H,
Scheer M, Thiele S, Wingender E: TRANSFAC: transcriptional
regulation, from patterns to profiles.  Nucleic Acids Res 2003,
31:374-8.
23. Karolchik D, Baertsch R, Diekhans M, Furey T, Hinrichs A, Lu Y,
Roskin K, Schwartz M, Sugnet C, Thomas D, Weber R, Haussler D,
Kent W, Kent W: The UCSC Genome Browser Database.
Nucleic Acids Res 2003, 31:51-4.
24. Podkolodnaya OA, Stepanenko IL: The ESRG-TRRD: database of
genes with specific transcription regulation in erythroid
cells.  1998 [http://wwwmgs.bionet.nsc.ru/mgs/papers/podkolod
naya/esg-trrd].
25. Yoshikawa T, Ide T, Shimano H, Yahagi N, Amemiya-Kudo M, Matsu-
zaka T, Yatoh S, Kitamine T, Okazaki H, Tamura Y, Sekiya M, Taka-
hashi A, Hasty AH, Sato R, Sone H, Osuga JI, Ishibashi S, Yamada N:
Cross-talk between peroxisome proliferator-activated
receptor (PPAR) alpha and liver X receptor (LXR) in nutri-
tional regulation of fatty acid metabolism. I. PPARs suppress
sterol regulatory element binding protein-1c promoter
through inhibition of LXR signaling.  Mol Endocrinol 2003,
17(7):1240-54.
26. Sprague J, Bayraktaroglu L, Clements D, Conlin T, Fashena D, Frazer
K, Haendel M, Howe D, Mani P, Ramachandran S, Schaper K, Seg-
erdell E, Song P, Sprunger B, Taylor S, Slyke CV, Westerfield M: The
Zebrafish Information Network: the zebrafish model organ-
ism database.  Nucleic Acids Res 2006:D581-5.
27. Krivan W, Wasserman W: A predictive model for regulatory
sequences directing liver-specific transcription.  Genome
Research 2001, 11(9):1559-1566.
28. Eagon P, Elm M, Stafford E, Porter L: Androgen receptor in
human liver: characterization and quantitation in normal
and diseased liver.  Hepatology 1994, 19(1):92-100.
29. Lecointe O, Bernard K, Naert V, Joulin C, Larsen P, Romej , D MM:
GATA-and SP1-binding sites are required for the full activity
of the tissue-specific promoter of the tal-1 gene.  Oncogene
1994, 9:2623-2632.
30. Humbert P, Rogers C, Ganiatsas S, Landsberg R, Trimarchi J, Danda-
pani S, Brugnara C, Erdman S, Schrenzel M, Bronson R, Lees J: E2F4
is essential for normal erythrocyte maturation and neonatal
viability.  Mol Cell 2000, 6(2):281-91.
31. Bockamp E, McLaughlin F, Gottgens B, Murrell A, Elefanty A, Green
A:  Distinct Mechanisms Direct SCL/tal-1 Expression in
Erythroid Cells and CD34 Positive Primitive Myeloid Cells.
Journal of Biological Chemistry 1997, 272(13):8781-8790.
32. Blobel G, Nakajima T, Eckner R, Montminy M, Orkin S: CREB-bind-
ing protein cooperates with transcription factor GATA-1
and is required for erythroid differentiation.  Proc Natl Acad Sci
USA 1998, 95(5):2061-2066.
33. Welch J, Watts J, Vakoc C, Yao Y, Wang H, Hardison R, Blobel G,
Chodosh L, Weiss M: Global regulation of erythroid gene
expression by transcription factor GATA-1.  Blood 2004,
104(10):3136-3147.
34. Dufour C, Wilson B, Huss J, Kelly D, Alaynick W, Downes M, Evans
R, Blanchette M, Giguere V: Genome-wide orchestration of car-
diac functions by the orphan nuclear receptors ERRalpha
and gamma.  Cell Metabolism 2007, 5(5):345-56.
35. Zhu W, TomHon C, Mason M, Campbell T, Shelden E, Richards N,
Goodman M, Gumucio D: Analysis of Linked Human epsilon
and gamma Transgenes: Effect of Locus Control Region
Hypersensitive Sites 2 and 3 or a Distal YY1 Mutation on
Stage-Specific Expression Patterns.  Blood 1999, 93(10):3540-9.
36. Crestani M, De Fabiani E, Caruso D, Mitro N, Gilardi F, Vigil Chacon
A, Patelli R, Godio C, Galli G: LXR (liver X receptor) and HNF-
4 (hepatocyte nuclear factor-4): key regulators in reverse
cholesterol transport.  Biochem Soc Trans 2004, 32(Pt 1):92-6.
37. Peterkin T, Gibson A, Loose M, Patient R: The roles of GATA-4, -
5 and -6 in vertebrate heart development.  Semin Cell Dev Biol
2005, 16(1):83-94.
38. Reimold A, Etkin A, Clauss I, Perkins A, Friend D, Zhang J, Horton H,
Scott A, Orkin A, Byrne M, Grusby M, Glimcher L: An essential role
in liver development for transcription factor XBP-1.  Genes
Dev 2000, 14(2):152-157.
39. Charron J, Malynn B, Fisher P, Stewart V, Jeannotte L, Goff S, Robert-
son E, Alt F: Embryonic lethality in mice homozygous for a tar-
geted disruption of the N-myc gene.  Genes Dev 1992,
6:2248-2257.